[Treatment of high blood cholesterol in patients with coronary heart disease]

Nihon Rinsho. 1994 Jul;52 Suppl(Pt 1):1088-94.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Anion Exchange Resins / adverse effects
  • Anion Exchange Resins / pharmacology
  • Anion Exchange Resins / therapeutic use
  • Bezafibrate / adverse effects
  • Bezafibrate / pharmacology
  • Bezafibrate / therapeutic use
  • Clinical Trials as Topic
  • Coronary Disease / etiology
  • Coronary Disease / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / drug therapy*
  • Hypolipidemic Agents* / adverse effects
  • Hypolipidemic Agents* / pharmacology
  • Hypolipidemic Agents* / therapeutic use
  • Niacin / adverse effects
  • Niacin / pharmacology
  • Niacin / therapeutic use
  • Probucol / adverse effects
  • Probucol / pharmacology
  • Probucol / therapeutic use
  • Risk Factors

Substances

  • Anion Exchange Resins
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Niacin
  • Probucol
  • Bezafibrate